# AB Science: Masitinib and AB8939 – Two compounds with breakthrough mechanism of action

> AB Science is currently developing two main compounds, masitinib, a highly selective tyrosine kinase inhibitor and AB8939\.

Generated by Yoast SEO v28.0, this is an llms.txt file, meant for consumption by LLMs.

## Pages
- [Assemblées Générales](https://www.ab-science.com/investors/regulated-information/shareholders-general-meeting/)
- [Shareholders General Meeting](https://www.ab-science.com/investors/regulated-information/shareholders-general-meeting/)
- [Statuts](https://www.ab-science.com/investors/regulated-information/articles-of-incorporation/)
- [Articles of Incorporation](https://www.ab-science.com/investors/regulated-information/articles-of-incorporation/)
- [Outstanding shares and voting rights](https://www.ab-science.com/investors/regulated-information/monthly-disclosure-of-total-outstanding-shares-and-voting-rights/)

## Posts
- [AB Science fait le point sur son programme clinique avec l’arrêt de certaines études cliniques non prioritaires en vue de se concentrer sur deux programmes cliniques](https://www.ab-science.com/ab-science-provides-an-update-on-its-clinical-program-suspending-some-non-priority-clinical-trials-to-focus-on-two-clinical-programs/)
- [AB Science provides an update on its clinical program, suspending some non\-priority clinical trials to focus on two clinical programs](https://www.ab-science.com/ab-science-provides-an-update-on-its-clinical-program-suspending-some-non-priority-clinical-trials-to-focus-on-two-clinical-programs/)
- [Le Conseil d'administration d’AB Science fait évoluer la gouvernance afin d'engager une nouvelle étape du développement de la société](https://www.ab-science.com/ab-sciences-board-of-directors-is-restructuring-its-governance-to-usher-in-a-new-phase-in-the-companys-development/)
- [AB Science’s Board of Directors is restructuring its governance to usher in a new phase in the company’s development](https://www.ab-science.com/ab-sciences-board-of-directors-is-restructuring-its-governance-to-usher-in-a-new-phase-in-the-companys-development/)
- [AB Science annonce le succès d’un placement prive de 2,3 millions d’euros](https://www.ab-science.com/ab-science-announces-the-successful-completion-of-a-eur-2-3-million-private-placement/)

## Categories
- [2021](https://www.ab-science.com/category/news/2021/)
- [2019](https://www.ab-science.com/category/news/2019/)
- [2020](https://www.ab-science.com/category/news/2020/)
- [2025](https://www.ab-science.com/category/news/2025/)
- [2024](https://www.ab-science.com/category/news/2024/)

## Tags
- [Masitinib](https://www.ab-science.com/tag/masitinib/)
- [2019](https://www.ab-science.com/tag/2019/)
- [ALS](https://www.ab-science.com/tag/als/)
- [AB10015](https://www.ab-science.com/tag/ab10015-2/)
- [riluzole](https://www.ab-science.com/tag/riluzole-2/)

## Optional
- [Sitemap index](https://www.ab-science.com/sitemap_index.xml)